This inventor holds 20 USPTO granted patents and 4 published patent applications, plus 2 CIPO patents and 10 EPO patents, primarily in Pharmaceutical Compounds. Top assignees: Karus Therapeutics Limited, Convalife (Shanghai) Co. Limited, Karus Therapeutic Limited. Active years: 2013-2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Southampton, GB (2015)
- Hampshire, GB (2013 - 2016)
- Abingdon, GB (2017 - 2018)
- Oxfordshire, GB (2017 - 2023)
Company Filing History:
17 out of 23 
2 out of 4 
1 out of 1 Years Active: 2013-2023
Areas of Expertise:
Title: **Franck Alexandre Silva: Innovator in Pharmaceutical Compounds**
Introduction
Franck Alexandre Silva is a distinguished inventor based in Oxfordshire, Great Britain, known for his significant contributions to the field of pharmaceuticals. With an impressive portfolio comprising 20 patents, Silva is recognized for his innovative work focused on compounds that have potential therapeutic applications.
Latest Patents
Two of Franck Alexandre Silva's latest patents showcase his expertise in pharmaceutical compositions. The first patent pertains to "Compounds comprising tricyclic heterocyclic compounds," which details a composition that includes specific tricyclic compounds alongside various pharmaceutical excipients. The second patent deals with "Tricyclic heterocyclic compounds as phosphoinositide 3-kinase inhibitors", outlining compounds represented by a specific formula that serve as inhibitors of the class IA phosphoinositide 3-kinase enzyme, which has implications for treating cancer, immune, and inflammatory diseases.
Career Highlights
Throughout his career, Franck Alexandre Silva has made significant strides in pharmaceutical research. He has worked with renowned companies such as Karus Therapeutics Limited and Convalife (Shanghai) Co. Limited, where he applied his knowledge of chemistry and pharmacology to develop important medicinal compounds that may influence therapeutic practices.
Collaborations
In his innovative journey, Franck has collaborated with notable individuals such as Stephen Joseph Shuttleworth and Alexander Richard Liam Cecil. Together, they have contributed to advancing research in the pharmaceutical domain, reflecting the collaborative spirit inherent in scientific discovery.
Conclusion
Franck Alexandre Silva is a remarkable inventor whose work has the potential to revolutionize therapeutic approaches in medicine. His dedication to exploring complex chemical compounds positions him as a key figure in the ongoing development of innovative pharmaceuticals aimed at treating challenging health conditions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile